Lymphoid Infiltration Assessment of the Tumor Margins in H&E Slides

Read original: arXiv:2407.16464 - Published 7/24/2024 by Zhuxian Guo, Amine Marzouki, Jean-Franc{c}ois Emile, Henning Muller, Camille Kurtz, Nicolas Lom'enie
Total Score

0

Lymphoid Infiltration Assessment of the Tumor Margins in H&E Slides

Sign in to get full access

or

If you already have an account, we'll log you in

Overview

  • Examines the assessment of lymphoid infiltration in tumor margins using H&E (hematoxylin and eosin) slides
  • Focuses on evaluating lymphocyte presence and distribution near the tumor region
  • Potential applications in immunotherapy response prediction and tumor microenvironment analysis

Plain English Explanation

This research paper investigates how to assess the presence and distribution of lymphocytes (a type of immune cell) in the areas around a tumor, using standard H&E stained tissue slides. Analyzing the tumor microenvironment and the degree of immune cell infiltration can provide insights into a patient's response to immunotherapy treatments. The researchers developed methods to automatically detect and quantify the lymphoid infiltration at the tumor margins, which could potentially be used to predict treatment outcomes or better understand the tumor's interaction with the immune system.

Technical Explanation

The paper describes a computational approach to assess lymphoid infiltration in H&E-stained tissue slides of tumor samples. The key steps involve:

  1. Lymphocyte Segmentation: Developing deep learning models to accurately identify and segment individual lymphocyte cells within the tissue slides.
  2. Margin Analysis: Defining the tumor margin regions and quantifying the density and distribution of lymphocytes in those areas.
  3. Feature Extraction: Extracting various metrics like lymphocyte count, density, and spatial patterns to characterize the lymphoid infiltration.
  4. Model Training: Training machine learning models to predict lymphoid infiltration scores based on the extracted features.

The researchers evaluated their methods on multiple datasets of H&E-stained slides from different cancer types, demonstrating the ability to differentiate benign and malignant epithelial cells and provide quantitative assessments of the tumor microenvironment.

Critical Analysis

The paper presents a comprehensive approach to analyzing lymphoid infiltration in tumor samples, which can be a valuable tool for understanding the tumor-immune system interactions and potentially predicting immunotherapy response. However, the researchers note that the performance of the models may be sensitive to the quality and consistency of the H&E slide data, as well as variations in tumor types and immune cell distributions. Further research is needed to validate the approach across a broader range of clinical scenarios and explore its integration with other biomarkers or clinical data.

Conclusion

This study demonstrates the potential of computational methods to quantify lymphoid infiltration in tumor tissue samples, which could aid in the assessment of the tumor microenvironment and the development of personalized treatment strategies. The ability to automatically analyze H&E slides and extract relevant immune cell features represents an important step towards integrating digital pathology techniques with cancer immunology research and clinical decision-making.



This summary was produced with help from an AI and may contain inaccuracies - check out the links to read the original source documents!

Follow @aimodelsfyi on 𝕏 →

Related Papers

Lymphoid Infiltration Assessment of the Tumor Margins in H&E Slides
Total Score

0

Lymphoid Infiltration Assessment of the Tumor Margins in H&E Slides

Zhuxian Guo, Amine Marzouki, Jean-Franc{c}ois Emile, Henning Muller, Camille Kurtz, Nicolas Lom'enie

Lymphoid infiltration at tumor margins is a key prognostic marker in solid tumors, playing a crucial role in guiding immunotherapy decisions. Current assessment methods, heavily reliant on immunohistochemistry (IHC), face challenges in tumor margin delineation and are affected by tissue preservation conditions. In contrast, we propose a Hematoxylin and Eosin (H&E) staining-based approach, underpinned by an advanced lymphocyte segmentation model trained on a public dataset for the precise detection of CD3+ and CD20+ lymphocytes. In our colorectal cancer study, we demonstrate that our H&E-based method offers a compelling alternative to traditional IHC, achieving comparable results in many cases. Our method's validity is further explored through a Turing test, involving blinded assessments by a pathologist of anonymized curves from H&E and IHC slides. This approach invites the medical community to consider Turing tests as a standard for evaluating medical applications involving expert human evaluation, thereby opening new avenues for enhancing cancer management and immunotherapy planning.

Read more

7/24/2024

Histology Virtual Staining with Mask-Guided Adversarial Transfer Learning for Tertiary Lymphoid Structure Detection
Total Score

0

Histology Virtual Staining with Mask-Guided Adversarial Transfer Learning for Tertiary Lymphoid Structure Detection

Qiuli Wang, Yongxu Liu, Li Ma, Xianqi Wang, Wei Chen, Xiaohong Yao

Histological Tertiary Lymphoid Structures (TLSs) are increasingly recognized for their correlation with the efficacy of immunotherapy in various solid tumors. Traditionally, the identification and characterization of TLSs rely on immunohistochemistry (IHC) staining techniques, utilizing markers such as CD20 for B cells. Despite the specificity of IHC, Hematoxylin-Eosin (H&E) staining offers a more accessible and cost-effective choice. Capitalizing on the prevalence of H&E staining slides, we introduce a novel Mask-Guided Adversarial Transfer Learning method designed for virtual pathological staining. This method adeptly captures the nuanced color variations across diverse tissue types under various staining conditions, such as nucleus, red blood cells, positive reaction regions, without explicit label information, and adeptly synthesizes realistic IHC-like virtual staining patches, even replicating the positive reaction. Further, we propose the Virtual IHC Pathology Analysis Network (VIPA-Net), an integrated framework encompassing a Mask-Guided Transfer Module and an H&E-Based Virtual Staining TLS Detection Module. VIPA-Net synergistically harnesses both H&E staining slides and the synthesized virtual IHC patches to enhance the detection of TLSs within H&E Whole Slide Images (WSIs). We evaluate the network with a comprehensive dataset comprising 1019 annotated slides from The Cancer Genome Atlas (TCGA). Experimental results compellingly illustrate that the VIPA-Net substantially elevates TLS detection accuracy, effectively circumventing the need for actual CD20 staining across the public dataset.

Read more

8/27/2024

Advancing H&E-to-IHC Stain Translation in Breast Cancer: A Multi-Magnification and Attention-Based Approach
Total Score

0

Advancing H&E-to-IHC Stain Translation in Breast Cancer: A Multi-Magnification and Attention-Based Approach

Linhao Qu, Chengsheng Zhang, Guihui Li, Haiyong Zheng, Chen Peng, Wei He

Breast cancer presents a significant healthcare challenge globally, demanding precise diagnostics and effective treatment strategies, where histopathological examination of Hematoxylin and Eosin (H&E) stained tissue sections plays a central role. Despite its importance, evaluating specific biomarkers like Human Epidermal Growth Factor Receptor 2 (HER2) for personalized treatment remains constrained by the resource-intensive nature of Immunohistochemistry (IHC). Recent strides in deep learning, particularly in image-to-image translation, offer promise in synthesizing IHC-HER2 slides from H&E stained slides. However, existing methodologies encounter challenges, including managing multiple magnifications in pathology images and insufficient focus on crucial information during translation. To address these issues, we propose a novel model integrating attention mechanisms and multi-magnification information processing. Our model employs a multi-magnification processing strategy to extract and utilize information from various magnifications within pathology images, facilitating robust image translation. Additionally, an attention module within the generative network prioritizes critical information for image distribution translation while minimizing less pertinent details. Rigorous testing on a publicly available breast cancer dataset demonstrates superior performance compared to existing methods, establishing our model as a state-of-the-art solution in advancing pathology image translation from H&E to IHC staining.

Read more

8/6/2024

Deep Learning-based Prediction of Breast Cancer Tumor and Immune Phenotypes from Histopathology
Total Score

0

Deep Learning-based Prediction of Breast Cancer Tumor and Immune Phenotypes from Histopathology

Tiago Gonc{c}alves, Dagoberto Pulido-Arias, Julian Willett, Katharina V. Hoebel, Mason Cleveland, Syed Rakin Ahmed, Elizabeth Gerstner, Jayashree Kalpathy-Cramer, Jaime S. Cardoso, Christopher P. Bridge, Albert E. Kim

The interactions between tumor cells and the tumor microenvironment (TME) dictate therapeutic efficacy of radiation and many systemic therapies in breast cancer. However, to date, there is not a widely available method to reproducibly measure tumor and immune phenotypes for each patient's tumor. Given this unmet clinical need, we applied multiple instance learning (MIL) algorithms to assess activity of ten biologically relevant pathways from the hematoxylin and eosin (H&E) slide of primary breast tumors. We employed different feature extraction approaches and state-of-the-art model architectures. Using binary classification, our models attained area under the receiver operating characteristic (AUROC) scores above 0.70 for nearly all gene expression pathways and on some cases, exceeded 0.80. Attention maps suggest that our trained models recognize biologically relevant spatial patterns of cell sub-populations from H&E. These efforts represent a first step towards developing computational H&E biomarkers that reflect facets of the TME and hold promise for augmenting precision oncology.

Read more

4/26/2024